Robotic assisted hepaticojejunostomy for choledochal cyst in children.
Phase 2
- Conditions
- Biliary dilatation
- Registration Number
- JPRN-jRCTs032180287
- Lead Sponsor
- Yamataka Atsuyuki
- Brief Summary
Robotic-assisted hepaticojejunostomy can be performed safely and successfully without any adverse events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Children with pelvic ureteral transitional stenosis and adapted to surgery, who go to or is hospitalized in Juntendo University Hospital Department of Children's Urology and Surgery
Exclusion Criteria
Patient who the researcher judged inappropriate as the subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse event occurrence rate: At the time of approach, consider whether there is complication after intraoperative or postoperative. Transition to laparotomy or laparoscopic surgery, blood transfusion practice, organ damage, vascular injury, postoperative bleeding, postoperative infection, pulmonary infarction, gas embolism
- Secondary Outcome Measures
Name Time Method 1) Surgical results: operation time, bleeding volume<br>2) postoperative course: postoperative Vital Sign, urine volume, body temperature, drainage volume, leukocytes / CRP values on days 1, 3 and 5 postoperatively, postoperative pain (VAS: Visual Analog Scale Evaluation), hospitalization period<br>3) Pathological examination: presence or absence of malignancy in resected bile duct<br>4) Overall survival period: existence of death, period from surgery to death